NCT05930561Phase 2Active not recruiting
4D-150 in Patients With Diabetic Macular Edema
Study sponsor: 4D Molecular Therapeutics
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2029-02-28Estimated
Enrollment · participants72Estimated
Source updated2026-08-21Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.